Brief: Santhera Announces Publication Of Long-Term Clinical Data With Vamorolone
Sept 22 (Reuters) - Santhera Pharmaceuticals Holding AG
SANN.S :
* SANTHERA ANNOUNCES PUBLICATION OF LONG-TERM CLINICAL DATA
WITH
VAMOROLONE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
* LONG-TERM STUDY SHOWED SIGNIFICANT CONTINUED CLINICAL
IMPROVEMENT OF ALL OUTCOMES MEASURED OVER AN 18-MONTH FOLLOW-UP
PERIOD
Source text for Eikon: ID:nGNE2hSGx7
Further company coverage: SANN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million